Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinion. Chang GC, Kapoor A, Lee CK, Su C, et al. Int J Cancer 2025 Jun 14. doi: 10.1002/ijc.35512.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang GC, Kapoor A, Lee CK, Su C, et al. Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinion. Int J Cancer 2025 Jun 14. doi: 10.1002/ijc.35512.
PMID: 40515576